Etiology and pathogenesis of Kawasaki disease

Progress in Pediatric Cardiology

Volumn 6, Issue 3, 1997, Pages 187-192

  Shulman, Stanford T ^a   Rowley, Anne H ^b  

^a NORTHWESTERN UNIVERSITY   (United States)

^b LOYOLA UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Etiology; Kawasaki disease; Pathogenesis; Vasculitis

Indexed keywords

ARTERY ENDOTHELIUM; ARTICLE; B LYMPHOCYTE; CLINICAL FEATURE; CORONARY ARTERY; ENDOTHELIUM CELL; HUMAN; IMMUNOPATHOLOGY; MACROPHAGE; MONOCYTE; MUCOCUTANEOUS LYMPH NODE SYNDROME; PATHOGENESIS; PRIORITY JOURNAL; T LYMPHOCYTE;

EID: 0030937311     PISSN: 10589813     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1058-9813(97)00189-6     Document Type: Article

References (48)

1. Yanagawa H, Nakamura Y, Kawasaki T, Shigematsu I. Nationwide epidemic of Kawasaki disease in Japan during winter of 1985-1986. Lancet 1986;2:1138-1139.
2. Salo E, Pelkonen P, Pettay O. Outbreak of Kawasaki syndrome in Finland. Acta Ped Scand 1986;75:75-80.
3. Shulman ST, McAuley JB, Pachman LM, Miller ML, Ruschhaupt DG. Epidemiology of Kawasaki syndrome in an urban US area with a small Asian population. Am J Dis Child 1987;141:420-425.
4. Fujita Y, Nakamura Y, Sakata K. Kawasaki disease in families. Pediatrics 1989;84:666-669.
5. Bell DM, Rink EW, Nitzkin JL, Hall CB. Kawasaki syndrome: description of two outbreaks of KD in the United States. N Engl J Med 1981;304:1568-1575.
6. Dean AG, Melish ME, Hicks R, Palumbo NE. An epidemic of Kawasaki syndrome in Hawaii. J Pediatr. 1982;100:552-557.
7. Centers for Disease Control. Kawasaki syndrome - Massachusetts. MMWR 1989;29:369-371.
8. Patriarca PA, Rogers MF, Morens DM, Schonberger LB, Kaminski RM, Burns JC, Glode MP. Kawasaki syndrome: association with the application of rug shampoo. Lancet 1982;2:578-580.
9. Lin F-YC, Bailowitz A, Koslowe P, Israel E, Kaslow RA. Kawasaki syndrome: a case-control study during an outbreak in Maryland. Am J Dis Child 1985;139:277-279.
10. Klein BS, Rogers MF, Patrican LA, White MC, Burgdorfer W, Schell WL, Kochel RI, Marchette NJ, McPerson JT, Nelson DB, Yolken RH, Wortmann D, Davis JP. Kawasaki syndrome: a controlled study of an outbreak in Wisconsin. Am J Epidemiol 1986;124:306-316.
11. Rauch AM, Kaplan SL, Nihill MR, Pappas PG, Hurwitz ES, Schonberger LB. Kawasaki syndrome clusters in Harris County, Texas, and Eastern North Carolina. Am J Dis Child 1988;142:441-444.
12. Davis RL, Waller PL, Mueller BA, Dykewicz CA, Schonberger LB. Kawasaki syndrome in Washington State. Arch Pediatr Adolesc Med 1995;149:66-69.
13. Shulman ST, Rowley AH. Does Kawasaki disease have a retroviral etiology? Lancet 1986;2:545-546.
14. Burns JC, Geha RS, Schneeberger EE, Newburger JW. Polymerase activity in lymphocyte culture supernatants from patients with Kawasaki disease. Nature 1986;323;814-816.
15. Rowley AH, Castro B, Levy J, Sullivan J, Koup R, Fresco R, Shulman ST. Failure to confirm the presence of a retrovirus in cultured lymphocytes from patients with Kawasaki syndrome. Pediatr Res 1991;29:417-419.
16. Melish ME, Marchette NJ, Kaplan JC, Kihara S, Chong D, Ho DD. Absence of significant RNA-dependent DNA polymerase activity in lymphocytes from patients with Kawasaki syndrome. Nature 1989;337:288-290.
17. Rowley AH, Shulman ST. The search for the etiology of Kawasaki disease. Pediatr Infect Dis 1987;6:506-508.
18. Abe J, Kotzin BL, Jujo K, Melish ME, Glode MP, Koksaka J. Selective expansion of T cells expressing T-cell receptor variable regions Vβ2 and Vβ8 in Kawasaki disease. PNAS 1992;89:4066-4070.
19. Leung DYM, Meissner HC, Fulton DR, Murray DL, Kotzin BL, Schlievert PM. Toxic shock syndrome toxin-secreting Staphylococcus aureus in Kawasaki syndrome. Lancet 1993;342:1385-1388.
20. Terai M, Miwa K, Williams T, Kabat W, Fukuyama M, Okajima Y, Igarashi H, Shulman ST. The absence of evidence of staphylococcal toxin involvement in the pathogenesis of Kawasaki disease. J Infect Dis 1995;172:558-561.
21. Melish ME, Parsonett J, Marchette N. Kawasaki syndrome (KD) is not caused by toxic shock syndrome toxin-1 (TSST-1) + staphylococci. Pediatr Res 1994;35:187A.
22. Peters J, Takahashi M. Presentation at Kawasaki disease symposium, Ospedale Pediatrico Bambino Gesu, Rome, Italy, May 1996.
23. Rowley AH, Gonzalez-Crussi F, Gidding SS, Duffy CE, Shulman ST. Incomplete Kawasaki disease with coronary artery involvement. J Pediatr 1987;110:409-413.
24. Choo Q, Kuo G, Weiner AJ, Overby LR, Bradley DW, Houghton M. Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome. Science 1989;244:359-362.
25. Rowley AH, Wolinsky SM, Relman DA, Sambol SP, Sullivan J, Terai M, Shulman ST. Search for highly conserved viral and bacterial nucleic acid sequences corresponding to an etiologic agent of Kawasaki disease. Pediatr Res 1994;36:567-571.
26. Relman DA. The identification of uncultured microbial pathogens. J Infect Dis 1993;168:1-8.
27. Liang P, Pardee AB. Differential display of eukaryotic messenger RNA by means of the polymerase chain reaction. Science 1992;257:967-971.
28. Lisitsyn NA, Lisitsyn NM, Wigler M. Cloning the differences between two complex genomes. Science 1993;259:946-951.
29. Chang Y, Cesarman E, Pessin MS, Lee F, Culpeper J, Knowles DM, Moore PS. Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma. Science 1994;266:1865-1869.
30. Rowen L, Koop BF, Hood L. The complete 685-kilobase DNA sequence of the human β T cell receptor locus. Science 1996;272:1755-1762.
31. Shulman ST, Delnocencio J, Hirsch R. Kawasaki disease. Pediatr Clin North Am 1995;42:1205-1222.
32. Barron K, DeCunto C, Montalvo J, Orson F, Lewis D. Abnormalities of immunoregulation in Kawasaki syndrome. J Rheumatol 1988;15:12-43.
33. Terai M, Kohno Y, Niwa K, Toba T, Sakurai N, Nakawima H. Imbalance among T-cell subsets in patients with arterial aneurysms in Kawaski disease. Am J Cardiol 1987;60:555.
34. Laxer RL, Schaffer FM, Myones BL, Yount WS, Rowe RD, Robin L, Silverman ED. Lymphocyte abnormalities and complement activation in Kawaski disease. Prog Clin Biol Res 1987;250:175.
35. Furukawa S, Matsubara T, Obara T, Okumura K, Yabuta K. Soluble CD2 levels in serum during acute Kawasaki disease and infectious mononucleosis. J Infect Dis 1993;167:778.
36. Terai M, Kohno Y, Namba M, Umemiya T, Niwa K. Class II major histocompatibility antigen expression on coronary arterial endothelium in a patient with Kawasaki disease. Hum Pathol 1991;21:231.
37. Nagata S, Yamashiro Y, Maeda M, Ohtsuka Y, Yabuta K. Immunohistochemical studies on small intestinal mucosa in Kawasaki disease. Pediatr Res 1993;33:557.
38. Pietra BA, De Inocencio J, Giannini EH, Hirsch R. TCR Vβ family repertoire and T cell activation markers in Kawasaki disease. J Immunol 1994;153:1881-1888.
39. Hingorani R, Choi I, Akolkar P, Gulwani-Akolkar B. Clonal predominance of T cell receptors within the CD8+ subset in normal human subjects. J Immunol 1993;151:5762.
40. Kobayashi S, Wada N, Kubo M. Antibodies to native type III collagen in the serum of patients with Kawasaki disease. Eur J Pediatr 1992;151:183.
41. Vaarala O, Salo E, Pelkonen P, Palosuo T, Aho K. Anticardiolipin response in Kawasaki disease. Acta Paediatr Scand 1990;79:804.
42. Shulman ST, Ronda N, Kazatchkine M. Sequential analysis of ANCA in IVIG-treated Kawasaki disease patients. Proceedings of Fifth International ANCA Workshop, Cambridge, England, Sept 1993.
43. Kohsaka T, Abe J, Asahina T, Kobayashi N. Classical pathway complement activation in Kawasaki syndrome. J Allergy Clin Immunol 1994;93:520.
44. Myones BL, Bathori JM, Yarygina O, Antonova E, Lehman TJA, Shulman ST. Complement depletion inhibits Lactobacillus casei-inducible coronary arteritis in a mouse model. In: Kato H, editor. Kawasaki Disease, Amsterdam: Elsevier, 1995.
45. Furukawa S, Matsubara T, Motohashi T, Nakachi S, Sasai K. Expression of FcER2/CD23 on peripheral blood macrophages in Kawasaki disease. Clin Immunol Immunopathol 1990;56:280.
46. Matsubara T, Furukawa S, Yabuta K. Serum levels of tumor necrosis factor interleukin 2 receptor, and interferon-γ in Kawasaki disease-involved coronary-artery lesions. Clin Immunol Immunopathol 1990;56:29.
47. Myones BL, Luckey JP, Corydon K, Shulman ST. Elevated neopterin levels in patients with Kawasaki disease correlate with fever and are indicative of macrophage activation. In: Takahashi M and Taubert K, editors. Proceedings of the Fourth International Symposium on Kawasaki disease; American Heart Association, 1993;162.
48. Sato N, Sagawa K, Sasaguri Y, Inoue O, Kato H. Immunopathology and cytokine detection in the skin lesions of patients with Kawasaki disease. J Pediatr 1993;22:198.